
Dr Elle Wadsworth interviews Dr Michelle Priest about psilocybin microdosing in the United States, discussing survey insights and policy implications.
In this episode, Dr Elle Wadsworth talks to Dr Michelle Priest, a research project specialist at RAND, US. The interview covers Michelle’s data insight looking at psilocybin microdosing in the US with insights from a nationally representative survey. What is microdosing? [01:09] The importance of looking at the prevalence of microdosing psilocybin in the US [02:52] The state and local policy landscape of psilocybin in the US [03:35] The nationally representative survey that Michelle and colleagues used [06:20] The key findings of the study [07:15] The reasons for microdosing psilocybin [08:26] The temporality of the microdosing questions [09:30] Why people didn’t know whether they microdosed [10:36] Who is microdosing psilocybin [12:02] Some surprising findings from the study [12:55] The implications of the findings for policy [14:00] The next steps in the RAND team for psychedelics [14:29] The take home messages of the study [15:32] About Elle Wadsworth: Elle is an research fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and…
Host: Dr Elle Wadsworth
Guest: Dr Michelle Priest
Organizations: RAND, Society for the Study of Addiction
Places: United States
Explore listener stats, chart rankings, contacts and more on the Addiction Audio podcast page.